Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samareh Younesian

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cells|November 11, 2022
The DNA Methylation in Neurological DiseasesSamareh Younesian, Amir-Mohammad Yousefi, Majid Momeny, et al.
Annals of Hematology|September 6, 2019
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemiaSamareh Younesian, Sepideh Shahkarami, Parisa Ghaffari, et al.
Heliyon|June 27, 2024
DNA methylation in human diseasesSamareh Younesian, Mohammad Hossein Mohammadi, Ommolbanin Younesian, et al.
Leukemia Research|September 5, 2017
DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemiaSamareh Younesian, Sepideh Shahkarami, Parisa Ghaffari, et al.
Cell Journal|February 25, 2023
Minimal Residual Disease Detection Using Gene Scanning Analysis, Fluorescent Fragment Analysis, and Capillary Electrophoresis for IgH Rearrangement in Adult B-Lineage Acute Lymphoblastic Leukemia: A Cross-Sectional StudySepideh Shahkarami, Samareh Younesian, Shahrbano Rostami, et al.
Annals of Hematology|February 3, 2018
Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL)Sepideh Shahkarami, Roya Mehrasa, Samareh Younesian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cells|November 11, 2022
The DNA Methylation in Neurological DiseasesSamareh Younesian, Amir-Mohammad Yousefi, Majid Momeny, et al.
Annals of Hematology|September 6, 2019
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemiaSamareh Younesian, Sepideh Shahkarami, Parisa Ghaffari, et al.
Heliyon|June 27, 2024
DNA methylation in human diseasesSamareh Younesian, Mohammad Hossein Mohammadi, Ommolbanin Younesian, et al.
Leukemia Research|September 5, 2017
DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemiaSamareh Younesian, Sepideh Shahkarami, Parisa Ghaffari, et al.
Cell Journal|February 25, 2023
Minimal Residual Disease Detection Using Gene Scanning Analysis, Fluorescent Fragment Analysis, and Capillary Electrophoresis for IgH Rearrangement in Adult B-Lineage Acute Lymphoblastic Leukemia: A Cross-Sectional StudySepideh Shahkarami, Samareh Younesian, Shahrbano Rostami, et al.
Annals of Hematology|February 3, 2018
Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL)Sepideh Shahkarami, Roya Mehrasa, Samareh Younesian, et al.
Pageof 1